M&A - UFP TECHNOLOGIES INC

Form Type: 10-Q

Filing Date: 2025-05-12

Corporate Action: Acquisition

Type: Update

Accession Number: 000117184325003049

Filing Summary: UFP Technologies, Inc. reported its financial results for the quarterly period ended March 31, 2025. The company disclosed an increase in net sales to $148.1 million compared to $105.0 million for the same period in 2024, with a net income of $17.2 million, up from $12.7 million year-over-year. The cost of sales rose to $106.0 million, leading to a gross profit of $42.2 million. The company recognized acquisition costs of $37 thousand related to the purchase of Marble Medical, which previously took place on June 24, 2024, for a total purchase price of approximately $5.0 million, plus contingent consideration based on sales performance. UFP Technologies also reported an adjustment to its financial positions, increasing total assets to $642.6 million and total liabilities to $282.0 million. The company’s stockholders’ equity amounted to $360.7 million, reflecting retained earnings of $323.7 million. The net cash provided by operating activities was reported at $13.8 million for the period, down from $10.7 million a year earlier. The financial statements included are unaudited but represent the company’s current financial standing and reflect its continued growth and operational effectiveness. Additionally, various commitments and contingencies related to operations and leases were noted, affirming the financial health and operational capacity of UFP Technologies, Inc.